Reference intervals for serum sphingosine-1-phosphate in the population-based Study of Health in Pomerania
Reference intervals for serum sphingosine-1-phosphate in the population-based Study of Health in Pomerania
复制标题
DOI:
10.1016/j.cca.2017.01.029
复制
发表时间:
2017-05-01
影响因子:
5
通讯作者:
Rauch, Bernhard H.
中科院分区:
文献类型:
--
作者:
Moritz, Eileen;Wegner, Danilo;Rauch, Bernhard H.
Background: The bioactive signaling lipid sphingosine-1-phosphate (S1P) is a potential biomarker for cardiovascular disease (CVD). To date, no reference intervals for S1P have been defined. This study aims to establish a reference range for serum S1P in healthy individuals.Methods: We determined reference intervals for S1P levels according to gender and age in a sample of 1339 healthy participants of the Study of Health in Pomerania (SHIP)-TREND cohort after exclusion of subjects with CVD, diabetes mellitus, hypertension, metabolic syndrome, elevated liver enzymes, chronic kidney disease stadium III or IV, or body mass index (BMI) > 30 kg/m(2). Serum S1P was measured by liquid chromatography-tandem mass spectrometry.Results: The median age of the participants was 41 (25th; 75th percentile 32; 51) years, 65% were women. The median serum concentration of S1P was 0.804 (0.694; 0.920) mu mol/L. No association with gender and age was observed. The overall reference interval was 0.534-1.242 mu mol/L (2.5th; 97.5th percentile). Further exclusion of smokers, individuals with BMI > 25 kg/m(2) or elevated lipid levels did not significantly affect median S1P concentrations.Conclusions: This study provides reference intervals for serum S1P in healthy individuals. Total serum SW concentrations vary irrespectively of age, gender, BMI or smoking status. (C) 2017 Elsevier B.V. All rights reserved.